6-(4-methoxyanilino)-1H-pyrimidine-2,4-dione | 72255-57-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 6-(4-methoxyanilino)-1H-pyrimidine-2,4-dione
• 英文别名: 6-(4-methoxyphenylamino)pyrimidine-2,4(1H,3H)-dione
• CAS: 72255-57-3
• 化学式: C₁₁H₁₁N₃O₃
• 分子量: 233.227
• InChiKey: KNFIZFJIHAXZLE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  79.5
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-(4-methoxyanilino)-1H-pyrimidine-2,4-dione 、 2-hydroxymethylene-17β-hydroxy-5α-androstan-3-one 在 对甲苯磺酸 作用下， 以 二苯醚 为溶剂， 以41%的产率得到(1S,14S,15S,18S,19S,22S,23R)-19-hydroxy-4-(4-methoxyphenyl)-14,18-dimethyl-4,6,8-triazahexacyclo[12.11.0.03,12.05,10.015,23.018,22]pentacosa-3(12),5,10-triene-7,9-dione
  参考文献：
  名称：

  New Synthesis and Biologically Active Molecular Design of Deazapteridine-Steroid Hybrid Compounds

  摘要：

  This paper describes a facile and general synthesis of a new class of the hybrid compounds (4, 5 and 16), possessing 5-deazapteridine and steroid in the same ring system, by condensation of 6-(monosubstituted amino)uracils (9) or 6-(monosubstituted amino)-2-phenylpyrimidin-4(3H)-ones (14) with 2-hydroxymethyleneandrostanolone (10) or 2-hydroxymethylenetestosterone (15) under heating in the presence of p-toluenesulfonic acid monohydrate and their potential unti-coccidiosis activities.

  DOI：

  10.3987/com-03-9925
• 作为产物：
  描述：

  6-氯尿嘧啶 、 甲氧苯胺 以 二乙二醇二甲醚 为溶剂， 以94%的产率得到6-(4-methoxyanilino)-1H-pyrimidine-2,4-dione
  参考文献：
  名称：

  枯草芽孢杆菌DNA聚合酶III的抑制剂。6-茴香尿嘧啶和6-（烷基氨基）尿嘧啶。

  摘要：

  发现取代的6-茴香胺嘧啶是来自枯草芽孢杆菌的复制特异性酶DNA聚合酶III的有效抑制剂。通过在苯环的间位和对位包含小烷基或卤素，可以最大程度地发挥抑制作用。极性取代基大大降低了活性。定性结构-活性关系表明，该元位置可以耐受较大的基团，这表明该位置可能适合引入能够不可逆地结合酶的基团。几种6-（烷基氨基）尿嘧啶是DNA聚合酶III的弱抑制剂。用于酶结合的最佳烷基是正戊基和正己基，它们显然可以占据平面酶结合位点。6-苯胺嘧啶对突变型DNA聚合酶的各种活性，

  DOI：

  10.1021/jm00175a007

文献信息

• UV₃₆₅ light promoted catalyst-free synthesis of pyrimido[4,5-<i>b</i>]quinoline-2,4-diones in aqueous-glycerol medium
  作者：Geetmani Singh Nongthombam、George Kupar Kharmawlong、John Elisa Kumar、Rishanlang Nongkhlaw

  DOI：10.1039/c8nj01459k

  日期：——

  Herein, a highly efficient and environmentally benign protocol for the synthesis of biologically important pyrimido[4,5-b]quinolinone-2,4-diones from aromatic amines, barbituric acid and aryl aldehyde is reported. This process takes place at room temperature under direct irradiation from a UV365 light source in the absence of a photocatalyst. The reported approach has several advantages such as high

  在此，报道了一种由芳族胺，巴比妥酸和芳基醛合成生物上重要的嘧啶并[4,5 - b ]喹啉酮-2,4-二酮的高效，环保的方法。该过程在室温下在不存在光催化剂的情况下在来自UV 365光源的直接照射下进行。报道的方法具有许多优势，例如高收率，干净的反应条件，无色谱法合成以及使用便宜的水-甘油溶剂系统，它也是一种环境友好的溶剂。该协议适用于大规模合成嘧啶并[4,5 - b ]喹啉酮-2,4-二酮而不浪费任何昂贵的化学药品是一个附加的优势。
• Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils
  作者：George E. Wright、Neal C. Brown

  DOI：10.1021/jm00175a007

  日期：1980.1

  irreversibly binding to the enzyme. Several 6-(alkylamino)uracils were weak inhibitors of DNA polymerases III; the optimum alkyl groups for enzyme binding were n-pentyl and n-hexyl, which apparently can occupy the planar enzyme binding site. The varied activities of 6-anilinouracils on a mutant DNA polymerase, resistant to 6-(phenylhydrazino)- and 6-(benzylamino)uracils bearing a p-OH or NH2 group, have altered

  发现取代的6-茴香胺嘧啶是来自枯草芽孢杆菌的复制特异性酶DNA聚合酶III的有效抑制剂。通过在苯环的间位和对位包含小烷基或卤素，可以最大程度地发挥抑制作用。极性取代基大大降低了活性。定性结构-活性关系表明，该元位置可以耐受较大的基团，这表明该位置可能适合引入能够不可逆地结合酶的基团。几种6-（烷基氨基）尿嘧啶是DNA聚合酶III的弱抑制剂。用于酶结合的最佳烷基是正戊基和正己基，它们显然可以占据平面酶结合位点。6-苯胺嘧啶对突变型DNA聚合酶的各种活性，
• Toxoflavins and Deazaflavins as the First Reported Selective Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase II
  作者：Ali Raoof、Paul Depledge、Niall M. Hamilton、Nicola S. Hamilton、James R. Hitchin、Gemma V. Hopkins、Allan M. Jordan、Laura A. Maguire、Alison E. McGonagle、Daniel P. Mould、Mathew Rushbrooke、Helen F. Small、Kate M. Smith、Graeme J. Thomson、Fabrice Turlais、Ian D. Waddell、Bohdan Waszkowycz、Amanda J. Watson、Donald J. Ogilvie

  DOI：10.1021/jm400568p

  日期：2013.8.22

  The recently discovered enzyme tyrosyl-DNA phosphodiesterase 2 (TDP2) has been implicated in the topoisomerase-mediated repair of DNA damage. In the clinical setting, it has been hypothesized that TDP2 may mediate drug resistance to topoisomerase II (topo II) inhibition by etoposide. Therefore, selective pharmacological inhibition of TDP2 is proposed as a novel approach to overcome intrinsic or acquired resistance to topo II-targeted drug therapy. Following a high-throughput screening (HTS) campaign, toxoflavins and deazaflavins were identified as the first reported sub-micromolar and selective inhibitors of this enzyme. Toxoflavin derivatives appeared to exhibit a clear structure-activity relationship (SAP.) for TDP2 enzymatic inhibition. However, we observed a key redox liability of this series, and this, alongside early in vitro drug metabolism and pharmacokinetics (DMPK) issues, precluded further exploration. The deazaflavins were developed from a singleton HTS hit. This series showed distinct SAR and did not display redox activity; however low cell permeability proved to be a challenge.
• Synthesis, biological active molecular design, and molecular docking study of novel deazaflavin–cholestane hybrid compounds
  作者：Ajaya R. Shrestha、Takashi Shindo、Noriyuki Ashida、Tomohisa Nagamatsu

  DOI：10.1016/j.bmc.2008.07.089

  日期：2008.9

  Novel deazaflavin-cholestane hybrid compounds, 3',8'-disubstituted-5'-deazacholest-2,4-dieno[2,3g] pteridine-2',4'(3'H, 8'H)-diones, have been synthesized by condensation reaction between 6-(monosubstituted amino)-pyrimidin-2,4(1H,3H)-diones and 2-hydroxymethylenecholest-4-en-3-one in presence of p-toluenesulfonic acid monohydrate and diphenyl ether. The antitumor activities against human tumor cell lines (CCRF-HSB-2 and KB cells) have been investigated in vitro, and many of these compounds showed promising antitumor activities. Furthermore, molecular docking study using LigandFit within the software package Discovery Studio 1.7 was done for lead optimization of these compounds as potential PTK inhibitors. In general, all of the synthesized steroid-hybrid compounds showed good binding affinities into PTK (PDB code: 1t46). (C) 2008 Elsevier Ltd. All rights reserved.
• A New and Convenient Synthesis of 10-Substituted 2,4,6,8-Tetraoxo- 2,3,4,6,7,8,9, 10-octahydropyrimido[5,4-<i>g</i>]pteridines as a Flavin Model
  作者：Tomohisa Nagamatsu、Hirotake Yamato、Kazuya Takai、Fumio Yoneda

  DOI：10.1055/s-1983-30426

  日期：——